Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604459 · ClinicalTrials.gov registry record · NA
Does Optimized General Anesthesia Care Reduce Postoperative Delirium?
A NA study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT02604459 is a NA study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 145 participants.
The verdict
NCT02604459, a NA study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
Postoperative delirium occurs in up to 65% of elders undergoing surgery for repair of a hip fracture and this complication is independently associated with increased morbidity, mortality, length of hospital stay, and placement in long-term care institutions. To date, the only intervention shown to be effective at minimizing postoperative delirium is a proactive geriatric consultation. This prospective randomized clinical trial will randomize 160 adults, aged 65 years or older, to either optimized general anesthesia or usual general anesthesia care for hip fracture surgery to determine if the optimized anesthesia management reduces the severity of postoperative delirium.
Interventions
- DRUG propofol
- PROCEDURE General anesthesia
- DEVICE cerebral oximeter (Fore-Sight)
- DEVICE depth of anesthesia monitor (BIS)
- PROCEDURE BP management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2018-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02604459
The ClinicalTrials.gov registry entry for NCT02604459 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which propofol is the first listed.
NCT02604459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02604459 about?
NCT02604459 is a clinical study titled "Does Optimized General Anesthesia Care Reduce Postoperative Delirium?". Postoperative delirium occurs in up to 65% of elders undergoing surgery for repair of a hip fracture and this complication is independently associated with increased morbidity, mortality, length of hospital stay, and placement in long-term care institutions. To date, the only intervention shown to b...
What is the current status of trial NCT02604459?
This trial is currently terminated. It is a NA study. The enrollment target is 145 participants. The study started on 2015-06-01. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT02604459?
The interventions under investigation include: propofol (DRUG), General anesthesia (PROCEDURE), cerebral oximeter (Fore-Sight) (DEVICE), depth of anesthesia monitor (BIS) (DEVICE), BP management (PROCEDURE).
Who is sponsoring clinical trial NCT02604459?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.